المؤلفون: Kaleem Bushra, Shahab Sadaf, Shamsi Tahir Sultan

المصدر: Advances in Laboratory Medicine, Vol 5, Iss 4, Pp 412-417 (2024)

مصطلحات موضوعية: bcr-abl, chronic myeloid leukaemia (cml), disease progression, overall survival, resistance, t315i mutation, Medical technology, R855-855.5

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2628-491X

URL الوصول: https://doaj.org/article/0107e7dd58ef4e24b1fef55ad1617cf2

المؤلفون: Ke Yang, Kai Fu, Hong Zhang, Xiaokun Wang, Kenneth K.W. To, Caibo Yang, Fang Wang, Zhe-Sheng Chen, Liwu Fu

المصدر: Molecular Cancer, Vol 23, Iss 1, Pp 1-13 (2024)

مصطلحات موضوعية: CBP, p300, Cell differentiation, Cell senescence, Chronic myeloid leukemia, T315I mutation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1476-4598

URL الوصول: https://doaj.org/article/792bbc389b5f426faabc9bc42e1b0226

المؤلفون: Huijun Mu, Jian Zou, Haiping Zhang

المصدر: Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S79-S85 (2024)

مصطلحات موضوعية: BCR::ABL1 gene, T315I mutation, Digital droplet polymerase chain reaction, Philadelphia chromosome, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137924000300; https://doaj.org/toc/2531-1379

URL الوصول: https://doaj.org/article/a78ab098cdfe42289b9564f87fe94424

المؤلفون: Valentin Garcia-Gutierrez, Fei Huang, Ajibade Ashaye, Mehul Dalal, Victor Laliman-Khara, Massimo Breccia, Megan Rutherford, Hoora Moradian, Petros Patos, Elias Joseph Jabbour

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: chronic myeloid leukemia, ponatinib, asciminib, T315I mutation, BCR::ABL1 (BCR-ABL1), major molecular response, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1455378/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/ed2b0ee3852f4e13af5b8674b7755ddf

المؤلفون: Tomassetti, Sarah, Lee, Jennifer, Qing, Xin

المصدر: Clinical Case Reports. 10(11)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Cancer, Rare Diseases, Hematology, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, asciminib, blast phase, chronic myelogenous leukemia, T315I mutation, Agricultural, veterinary and food sciences, Biomedical and clinical sciences, Health sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/9878f8bv

المؤلفون: Adolfo Fernández-Sánchez, Alberto Hernández-Sánchez, Cristina De Ramón, María-Carmen Chillón, María Belén Vidriales, Mónica Baile-González, Cristina-Teresa Fuentes-Morales, Magdalena Sierra-Pacho, Lucía López-Corral, Fermín Sánchez-Guijo

المصدر: Biomedicines, Vol 12, Iss 10, p 2339 (2024)

مصطلحات موضوعية: chronic myeloid leukemia, blast phase, core binding factor rearrangement, T315I mutation, Biology (General), QH301-705.5

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2227-9059/12/10/2339; https://doaj.org/toc/2227-9059

URL الوصول: https://doaj.org/article/cea8bab0bfc94295884f241fa408384f

المؤلفون: Mobachir El Kettani, Kashish Shah, Hareem Farooq, Ke Li, Talha Badar

المصدر: Leukemia Research Reports, Vol 22, Iss , Pp 100471- (2024)

مصطلحات موضوعية: Chronic myeloid leukemia, T315i mutation, Blast crisis, Neurotological involvement, Tyrosine kinase inhibitors, atypical presentation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S221304892400061X; https://doaj.org/toc/2213-0489

URL الوصول: https://doaj.org/article/62f4c8a241264fe78203ec013ad0da8b

المؤلفون: Anupam Sarma, Amal Chandra Kataki, Avdhesh Kumar Rai, Munlima Hazarika, Partha Sarathi Roy, Manoj Kalita, Manab Deka, Indranil Chattopadhyay

المصدر: Asian Pacific Journal of Cancer Care, Vol 8, Iss 1, Pp 35-42 (2023)

مصطلحات موضوعية: chronic myeloid leukemia, t315i mutation, promoter hypermethylation, imatinib mesylate, median survival, north-east india, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.waocp.com/journal/index.php/apjcc/article/view/967; https://doaj.org/toc/2588-3682

URL الوصول: https://doaj.org/article/67ede0c1b31042dbb145137ea02d4d22

المؤلفون: Qian Jiang, Zongru Li, Yazhen Qin, Weiming Li, Na Xu, Bingcheng Liu, Yanli Zhang, Li Meng, Huanling Zhu, Xin Du, Suning Chen, Yang Liang, Yu Hu, Xiaoli Liu, Yongping Song, Lichuang Men, Zi Chen, Qian Niu, Hengbang Wang, Ming Lu, Dajun Yang, Yifan Zhai, Xiaojun Huang

المصدر: Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-17 (2022)

مصطلحات موضوعية: Chronic myeloid leukemia, Chronic phase, Accelerated phase, T315I mutation, Tyrosine kinase inhibitor, Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1756-8722

URL الوصول: https://doaj.org/article/345be4aeb4514069944647b77273de81

المؤلفون: Mokhlesi, Omalbanin, Sadeghian, Mohammad Hadi, Shajiei, Arezoo, Sheikhi, Maryam, Siyadat, Payam, Kooshyar, Mohammad Mehdi, Rahimi, Hossein, Amini, Nafiseh, Dadgar Moghadam, Maliheh, Ayatollahi, Hossein, Shams, Seyyede Fatemeh, Khoshnegah, Zahra

المصدر: Journal of Advances in Medical and Biomedical Research, 31(146), 244-249, (2023-03-13)

مصطلحات موضوعية: T315I Mutation, Chronic Myeloid Leukemia (CML), Imatinib Resistance

Relation: https://doi.org/10.30699/jambs.31.146.244; oai:zenodo.org:8251394

الاتاحة: https://doi.org/10.30699/jambs.31.146.244

المؤلفون: Franck-Emmanuel Nicolini, Françoise Huguet, Lynn Huynh, Churong Xu, Christophe Bouvier, Aurore Yocolly, Gabriel Etienne

المصدر: Cancers; Volume 15; Issue 16; Pages: 4161

مصطلحات موضوعية: chronic-phase chronic myeloid leukemia (CML-CP), tyrosine kinase inhibitor (TKI), treatment patterns, overall survival, T315I mutation

وصف الملف: application/pdf

Relation: Tumor Microenvironment; https://dx.doi.org/10.3390/cancers15164161

الاتاحة: https://doi.org/10.3390/cancers15164161

المؤلفون: Honglan Qian, Dongxu Gang, Xiaoyu He, Songfu Jiang

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: olverembatinib, chronic myeloid leukemia, tyrosine kinase inhibitors, breakpoint cluster region protein and abelson tyrosine-protein kinase 1, T315I mutation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.1036437/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/f64df5eaf56f4047833f88b7ea030076

المؤلفون: Sarah Tomassetti, Jennifer Lee, Xin Qing

المصدر: Clinical Case Reports, Vol 10, Iss 11, Pp n/a-n/a (2022)

مصطلحات موضوعية: asciminib, blast phase, chronic myelogenous leukemia, T315I mutation, Medicine, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2050-0904

URL الوصول: https://doaj.org/article/694eeb2f056144a69aeca08031a81550

المؤلفون: Liang Jiang, Yuting Wang, Qian Li, Zhengchao Tu, Sihua Zhu, Sanfang Tu, Zhang Zhang, Ke Ding, Xiaoyun Lu

المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 5, Pp 1315-1328 (2021)

مصطلحات موضوعية: CML, PROTAC, Degradation, T315I mutation, Clinical resistance, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2211383520307991; https://doaj.org/toc/2211-3835

URL الوصول: https://doaj.org/article/59ba973a56784e7ca3dac5b58fc8567e

المؤلفون: Hiroshi HASHIMOTO, Hitoshi HANAMOTO, Kaori YAMADA, Ryosuke FUJIWARA, Takahiro SHIMADA, Yuhei TAMURA, Yuriko KATOH, 加藤 由里子, 山田 薫, 嶋田 高広, 橋本 博史, 田村 雄平, 花本 仁, 藤原 亮介

المصدر: 臨床血液 / Rinsho Ketsueki. 2023, 64(8):746

المؤلفون: Riyam Qusay Ibrahim Al-Jadir, Jaffar Nouri Alalsaidissa

المصدر: Iraqi Journal of Hematology, Vol 9, Iss 2, Pp 131-137 (2020)

مصطلحات موضوعية: chronic myelogenous leukemia, t315i mutation, tyrosine kinase inhibitor resistance, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=131;epage=137;aulast=Al-Jadir; https://doaj.org/toc/2072-8069

URL الوصول: https://doaj.org/article/70432d0f80b24c7aadaf0bbebe84f091

المؤلفون: Musteaţă, V.G., Мустяцэ, В.Г.

المصدر: Journal of B.U.ON. 26 (3) 1165-1168

مصطلحات موضوعية: chronic myeloid leukemia, lactate dehydrogenase, P210 transcript of the, BCR-ABL chimeric gene, relapse, T315I mutation, Tyrosine kinase inhibitors

وصف الملف: application/pdf

Relation: https://ibn.idsi.md/vizualizare_articol/136975

الاتاحة: https://ibn.idsi.md/vizualizare_articol/136975

المؤلفون: K. I. Zarubina, E. N. Parovichnikova, O. A. Gavrilina, A. N. Sokolov, V. V. Troitskaya, L. A. Kuzmina, V. E. Mamonov, G. M. Galstyan, V. G. Savchenko

المصدر: Онкогематология, Vol 12, Iss 3, Pp 41-49 (2017)

مصطلحات موضوعية: ph-positive acute lymphoblastic leukemia, tyrosine kinase inhibitors, selectivity, combined toxicity, t315i mutation, imatinib, nilotinib, dasatinib, axitinib, ponatinib, blinatumomab, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://oncohematology.abvpress.ru/ongm/article/view/257; https://doaj.org/toc/1818-8346; https://doaj.org/toc/2413-4023

URL الوصول: https://doaj.org/article/ccbc7c4b11d244ae8ba5dbc2e2e7d0c0

المؤلفون: Caterina De Benedittis, Cristina Papayannidis, Claudia Venturi, Maria Chiara Abbenante, Stefania Paolini, Sarah Parisi, Chiara Sartor, Michele Cavo, Giovanni Martinelli, Simona Soverini

المصدر: BMC Cancer, Vol 17, Iss 1, Pp 1-6 (2017)

مصطلحات موضوعية: BCR-ABL1 mutation, T315I mutation, Ph+ Acute Lymphoblastic Leukemia, Resistance, Case Report, Relapse, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-017-3511-2; https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/b3195120be444a34be60520eafc3cbcd

المؤلفون: Zhang Zhang, Sihua Zhu, Qian Li, Sanfang Tu, Ke Ding, Liang Jiang, Zhengchao Tu, Yuting Wang, Xiaoyun Lu

المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 5, Pp 1315-1328 (2021)
Acta Pharmaceutica Sinica. B

مصطلحات موضوعية: Drug resistance, RM1-950, medicine.disease_cause, LSCs, leukemic stem cells, T315i mutation, IC50, cellular inhibition, T315I mutation, 03 medical and health sciences, PROTAC, Degradation, 0302 clinical medicine, CML, chronic myeloid leukemia, hemic and lymphatic diseases, T315I, threonine 315 to isoleucine 315, medicine, General Pharmacology, Toxicology and Pharmaceutics, Threonine, CRBN, cereblon, IC50, CML, 030304 developmental biology, 0303 health sciences, Mutation, TGI, tumor growth inhibition, Chemistry, NMPA, National Medical Products Administration, Myeloid leukemia, PROTAC, proteolysis-targeting chimeric, Pomalidomide, ALL, acute lymphoblastic leukemia, VHL, von Hippel-Lindau, 030220 oncology & carcinogenesis, DR, degradation rate, Cancer research, Original Article, Ph+, Philadelphia chromosome, Clinical resistance, Therapeutics. Pharmacology, Isoleucine, Co-IP, co-immunoprecipitation, cIAP1, cellular inhibitor of apoptosis protein 1, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46d7e646ae40d932bccd80bff158248
http://www.sciencedirect.com/science/article/pii/S2211383520307991